CHMP recommends 11 new medicines for authorization, including two COVID-19 monoclonal antibodies
Regulatory NewsJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyEuropePharmaceuticalsRegulatory NewsJoanne S. EglovitchBiologics/ biosimilars/ vaccinesBiotechnologyEuropePharmaceuticals